Description

Buy Enhertu For Sale In USA

What is Enhertu?

Enhertu (fam-trastuzumab-deruxtecan) is a s a HER2-directed antibody and topoisomerase inhibitor conjugate that is used to treat types of breast cancer,  stomach cancer and non-small cell lung cancer that have specific HER2 gene mutations.

Enhertu works by blocking HER2 receptors on cancer cells to prevent cancer cells from multiplying, which slows the cancer growth and progression, and then its second action is to damage or kill the cancer cells. Buy Enhertu For Sale In USA

Enhertu is made up of two cancer-fighting medicines joined together, a monoclonal antibody (fam-trastuzumab) and a chemotherapy drug (topoisomerase I inhibitor). Enhertu is an HER2-directed antibody and topoisomerase inhibitor conjugate.

Enhertu is an HER2 inhibitor which is a targeted therapy used to treat cancer. The FDA first approved Enhertu on December 20, 2019.

What is Enhertu used for?

Enhertu is FDA-approved for use in adult patients who have:

Breast cancer that is (HER2)-positive that is not removable by surgery or has spread and has already had a specific anti-HER2-based regimen.

Breast cancer that is HER2-low (IHC 1+ or IHC 2+/ISH-) that is not removable by surgery or has spread to other parts of your body, and who have already had chemotherapy for cancer that has spread or cancer has returned within 6 months of finishing adjuvant chemotherapy.

Stomach cancer that is HER2-positive that is gastric or gastroesophageal junction (GEJ) adenocarcinoma cancer, and you have already had a trastuzumab-based regimen and cancer has spread to areas near your stomach (locally advanced) or has spread to other parts of your body (metastatic). Buy Enhertu For Sale In USA

Non-small cell lung cancer (NSCLC) that has activating HER2 (ERBB2) mutations that cannot be removed by surgery or cancer that has spread to other parts of your body (metastatic), and you have already had systemic therapy, and activating HER2 (ERBB2) mutations have been detected by an FDA-approved test.

Enhertu (fam-trastuzumab deruxtecan-nxki) is not the same medicine as trastuzumab (Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera). These medicines contain only the trastuzumab, they do not contain topoisomerase I inhibitor.

Enhertu (fam-trastuzumab deruxtecan-nxki) is not the same medicine as Kadcyla (ado-trastuzumab emtansine) which has a different antibody-drug conjugate.

What is the HER2 gene?

Some cancer cells have too many copies of the human epidermal growth factor receptor 2 (HER2) gene, which makes a protein called the HER2, these cancers are called HER2 positive.  HER2 is a protein that controls cell growth, if your cancer is HER2 positive, it means it will more likely grow faster, spread, or come back.  Some cancer cells that are HER2-negative still have a number of HER2 proteins on the surface of the cells, these cancer cells are called HER2-low. Cancer medicines like Enhertu block HER2 receptors to reduce the ability of the cancer to grow and spread. Buy Enhertu For Sale In USA